Rheumatology workforce
Christie M Bartels, MD,MS
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Thomas Tack, n/a
American College of Rheumatology
Wilmington, Delaware, United States
Disclosure information not submitted.
The first year where rheumatology providers could choose to report for Traditional MIPS, the new rheumatology-specific MIPS Value Pathway (MVP), or both, was 2023. So, how did it go, and what does this mean for 2024 reporting? This session aims to answer those questions in three parts. First, a RISE registry staff member will review data that came from the 2023 reporting season, particularly between MIPS and the MVP, and how certain quality reporting practices, such as measure selection, impacted scores. Next, a provider who reported for both options in 2023 will speak about their experience and share what lessons they learned. Finally, the session culminates in a preview of what to expect for 2024 reporting and a discussion of strategies for providers to help them navigate the program options.
Speaker: Thomas Tack, n/a – American College of Rheumatology
Speaker: Christie M Bartels, MD,MS – University of Wisconsin School of Medicine and Public Health